These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
352 related articles for article (PubMed ID: 28799854)
21. Brain-Specific Cytoskeletal Damage Markers in Cerebrospinal Fluid: Is There a Common Pattern between Amyotrophic Lateral Sclerosis and Primary Progressive Multiple Sclerosis? Abdelhak A; Junker A; Brettschneider J; Kassubek J; Ludolph AC; Otto M; Tumani H Int J Mol Sci; 2015 Jul; 16(8):17565-88. PubMed ID: 26263977 [TBL] [Abstract][Full Text] [Related]
22. Measurement of cystatin C levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Ren Y; Zhu W; Cui F; Yang F; Chen Z; Ling L; Huang X Int J Clin Exp Pathol; 2015; 8(5):5419-26. PubMed ID: 26191245 [TBL] [Abstract][Full Text] [Related]
23. Biomarkers in cerebrospinal fluid for amyotrophic lateral sclerosis phenotypes. Zhou J; Zeng Q; Liao Q; Niu Q; Gu W; Su D; Li S; Xiao B; Bi F Ann Clin Transl Neurol; 2023 Aug; 10(8):1467-1480. PubMed ID: 37350306 [TBL] [Abstract][Full Text] [Related]
27. Proteome analysis of cerebrospinal fluid in amyotrophic lateral sclerosis (ALS). Brettschneider J; Mogel H; Lehmensiek V; Ahlert T; Süssmuth S; Ludolph AC; Tumani H Neurochem Res; 2008 Nov; 33(11):2358-63. PubMed ID: 18481174 [TBL] [Abstract][Full Text] [Related]
28. Proteomic analysis of exosome-enriched fractions derived from cerebrospinal fluid of amyotrophic lateral sclerosis patients. Hayashi N; Doi H; Kurata Y; Kagawa H; Atobe Y; Funakoshi K; Tada M; Katsumoto A; Tanaka K; Kunii M; Nakamura H; Takahashi K; Takeuchi H; Koyano S; Kimura Y; Hirano H; Tanaka F Neurosci Res; 2020 Nov; 160():43-49. PubMed ID: 31669371 [TBL] [Abstract][Full Text] [Related]
29. [Biomarkers for amyotrophic lateral sclerosis]. Tokuda T Brain Nerve; 2012 May; 64(5):515-23. PubMed ID: 22570065 [TBL] [Abstract][Full Text] [Related]
30. Phosphoneurofilament heavy chain and N-glycomics from the cerebrospinal fluid in amyotrophic lateral sclerosis. Gonçalves M; Tillack L; de Carvalho M; Pinto S; Conradt HS; Costa J Clin Chim Acta; 2015 Jan; 438():342-9. PubMed ID: 25261856 [TBL] [Abstract][Full Text] [Related]
31. Neurofilaments as Biomarkers for Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis. Xu Z; Henderson RD; David M; McCombe PA PLoS One; 2016; 11(10):e0164625. PubMed ID: 27732645 [TBL] [Abstract][Full Text] [Related]
33. Deep Dive on the Proteome of Human Cerebrospinal Fluid: A Valuable Data Resource for Biomarker Discovery and Missing Protein Identification. Macron C; Lane L; Núñez Galindo A; Dayon L J Proteome Res; 2018 Dec; 17(12):4113-4126. PubMed ID: 30124047 [TBL] [Abstract][Full Text] [Related]
34. Transglutaminase activity in serum and cerebrospinal fluid in sporadic amyotrophic lateral sclerosis: a possible use as an indicator of extent of the motor neuron loss. Fujita K; Honda M; Hayashi R; Ogawa K; Ando M; Yamauchi M; Nagata Y J Neurol Sci; 1998 Jun; 158(1):53-7. PubMed ID: 9667778 [TBL] [Abstract][Full Text] [Related]
35. Total tau is increased, but phosphorylated tau not decreased, in cerebrospinal fluid in amyotrophic lateral sclerosis. Wilke C; Deuschle C; Rattay TW; Maetzler W; Synofzik M Neurobiol Aging; 2015 Feb; 36(2):1072-4. PubMed ID: 25453560 [TBL] [Abstract][Full Text] [Related]
36. Identification of miRNAs as Potential Biomarkers in Cerebrospinal Fluid from Amyotrophic Lateral Sclerosis Patients. Benigni M; Ricci C; Jones AR; Giannini F; Al-Chalabi A; Battistini S Neuromolecular Med; 2016 Dec; 18(4):551-560. PubMed ID: 27119371 [TBL] [Abstract][Full Text] [Related]
37. Glial fibrillary acidic protein as a marker of astrocytic activation in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Benninger F; Glat MJ; Offen D; Steiner I J Clin Neurosci; 2016 Apr; 26():75-8. PubMed ID: 26602604 [TBL] [Abstract][Full Text] [Related]
38. CSF and blood biomarkers in amyotrophic lateral sclerosis: protocol for a systematic review and meta-analysis. Agah E; Saleh F; Sanjari Moghaddam H; Saghazadeh A; Tafakhori A; Rezaei N Syst Rev; 2018 Dec; 7(1):237. PubMed ID: 30572951 [TBL] [Abstract][Full Text] [Related]
39. Discovery of Biomarkers for Amyotrophic Lateral Sclerosis from Human Cerebrospinal Fluid Using Mass-Spectrometry-Based Proteomics. Oh S; Jang Y; Na CH Biomedicines; 2023 Apr; 11(5):. PubMed ID: 37238921 [TBL] [Abstract][Full Text] [Related]